The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers
- 31 January 1999
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (1), 47-53
- https://doi.org/10.1016/s0959-8049(98)00297-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumour marker changesThe Breast, 1996
- CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative studyEuropean Journal Of Cancer, 1995
- Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?British Journal of Cancer, 1993
- Continuous cytotoxics in responsive metastatic breast cancer: A role for tumour markersThe Breast, 1992
- Objective measurement of therapeutic response in breast cancer using tumour markersBritish Journal of Cancer, 1991
- An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical dataBritish Journal of Cancer, 1990
- Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyEuropean Journal of Cancer and Clinical Oncology, 1989
- The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breastEuropean Journal of Cancer and Clinical Oncology, 1988
- Serial tests of carcinoembryonic antigen in patients with breast cancerAmerican Journal of Clinical Oncology, 1983
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977